• No results found

Katarina Junevik Studies on therapeutic vaccination and immune evasion in chronic lymphocytic leukemia2013

N/A
N/A
Protected

Academic year: 2022

Share "Katarina Junevik Studies on therapeutic vaccination and immune evasion in chronic lymphocytic leukemia2013"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Katarina Junevik Studies on therapeutic vaccination and immune evasion in chronic lymphocytic leukemia

Studies on therapeutic vaccination and immune evasion in chronic lymphocytic leukemia

2013

ISBN 978-91-628-8720-9

Printed by Ineko AB, Gothenburg

Katarina Junevik

Institute of Biomedicine at Sahlgrenska Academy University of Gothenburg

References

Related documents

In study III, ILIT-1000, 1000SQ-U/ml were used for the three lymph node injections of birch and grass allergen. FNA and peripheral blood were sampled before the treatment and 2-4

Papers II and III demonstrate that anti-CD20 monoclonal antibodies (mAbs) triggered ROS production by monocytes and neutrophils, which translated into reduced NK

Papers II and III demonstrate that anti-CD20 mono- clonal antibodies (mAbs) triggered ROS production by monocytes and neutrophils, which translated into reduced NK

DCs are antigen presenting cells (APCs) which in contrast to other APCs (B cells, macrophages) are able to activate T cells. DCs have four functions that contribute to T

The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL). Annals of

My work has shown the DNA methylation has a prominent role on regulating the gene expression in CLL and also the percentage of DNA methylation can be used as an independent

In paper I, we screened a population-based cohort of CLL patients (n=364) for TP53, NOTCH1, SF3B1, BIRC3 and MYD88 mutations using Sanger sequencing, and confirmed

Multivariate analysis of TFS including the high- risk parameters (short telomeres, Binet stage B/C, CD38 and ZAP70 positivity, unmutated IGHV genes and